inflammatory%20bowel%20disease
INFLAMMATORY BOWEL DISEASE
Inflammatory bowel disease consists of ulcerative colitis and Crohn's disease.
Ulcerative colitis is a diffuse mucosal inflammation limited to the colon while Crohn's disease is a patchy, transmural inflammation that occurs in any part of the gastrointestinal tract.
The ileum and colon are the most frequently affected sites.

Introduction

  • Consists of ulcerative colitis (UC) and Crohn’s disease (CD)
    • UC: Diffuse mucosal inflammation limited to the colon
    • CD: Patchy, transmural inflammation that can occur in any part of the GI tract
      • Ileum and colon are the most frequently affected sites

Signs and Symptoms

General Symptoms

Depend on the segment of the intestinal tract involved

  • Chronic diarrhea or constipation
  • Abdominal pain and cramps
  • Blood in stool
  • Pain with bowel movement
  • Urgency in bowel movement
  • Tenesmus
  • Reduced appetite
  • Weight loss
  • Fever
  • Fatigue
  • Growth retardation
  • Primary amenorrhea
  • Night sweats

Clinical Features

Ulcerative Colitis (UC)

  • Cardinal symptoms: Bloody diarrhea, frequent, small volume
  • Associated symptoms: Colicky abdominal pain, tenesmus, urgency

Crohn's Disease (CD)

  • Chronic diarrhea, abdominal pain, weight loss
  • Abdominal mass, perianal lesions, stomatitis, fissures and fistulas
  • Malaise, fever, anorexia are more common with CD than UC

Risk Factors

Risk Factors

  • Smoking is a risk factor for CD but has a protective factor for UC through unknown mechanism
  • Age - most people are diagnosed between 15 and 35 years
  • UC is more common in men while CD is more frequent in women
  • Family history
  • Recent episodes of infectious gastroenteritis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Nov 2013

Joint stiffness is defined as discomfort after a period of inactivity. It is associated with reduced or loss of range of motion in a joint.

01 Aug 2016
Etoricoxib exhibits a central mode of action and enhances pain and function in patients with painful knew osteoarthritis (OA), as presented in a randomised, double-blind, placebo-controlled, two-way crossover, four-week treatment study.
Stephen Padilla, 25 Nov 2016
The addition of supervised physiotherapy to usual care does not provide clinically important improvement in the management of simple ankle sprains in a general population of patients seeking hospital-based acute care, according to results of a recent randomized controlled trial.
24 Jul 2017
The toxic side-effects of chemotherapy appear to be induced by cell-free chromatin (cfCh) fragments released from dying cells, triggering DNA damage, apoptosis and inflammation in healthy cells, thereby exaggerating or amplifying the toxic effects caused by the drugs themselves, according to a study.